Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.
about
Alcohol, nicotine, caffeine, and mental disordersPharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6Impact of smoking on lung cancer treatment effectiveness: a review.Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort studyDesign, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.The genetics of nicotine dependence: relationship to pancreatic cancer.Association of CYP2A6*4 with susceptibility of lung cancer: a meta-analysis.Associations of CYP2A6 genotype with smoking behaviors in southern China.Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.Candidate gene case-control studies.Phenotypic CYP2A6 variation and the risk of pancreatic cancer.Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.Toward individualized pharmaceutical care of East Asians: the value of genetic testing for polymorphisms in drug-metabolizing genes.Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer ConsortiumAssociated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer ConsortiumOverview of the pharmacogenomics of cigarette smoking.Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer.CYP2A6 polymorphisms and risk for tobacco-related cancers.Cytochrome P450 2A6 deletion polymorphism and risk of lung cancer: a meta-analysis.Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.Inter-gene correlation on oligonucleotide arrays: how much does normalization matter?Association between CYP2A6 genetic polymorphisms and lung cancer: a meta-analysis of case-control studies.Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma.CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis.CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy.Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.
P2860
Q24635635-234DDFE5-3160-4753-96ED-BE9ADD9A00CBQ27012807-72A170A7-65E1-4254-9BC6-9C7B0F2BEBC2Q30248968-F7BA69EE-3D47-4247-BECF-ECE78928CE16Q33728649-B6C25E68-5776-4EE0-AAB6-461F07BC77E2Q33803436-0A575EFF-20F7-4EE4-B927-38ECF2394AFDQ33866866-9CC7EAFB-4BFB-4FF5-90CC-DD1B936F4A8AQ34667734-13FD3D23-2EC5-4F84-84BA-9DBEF174EBA9Q34778875-DE68BAA6-5D9A-4E8D-A9D4-05F42B0CB74DQ35016329-592FFB9D-B816-4FB1-AC4E-83EA76830F6DQ35027945-D8B59211-24B5-4C3B-BDA4-D96E2186CA3AQ35073279-FBB70DBC-0372-40A3-AC39-ADFE62CE23A4Q35428436-04CA3B57-F14C-46F1-A791-0B0910536172Q35539136-BC52355C-20A1-4660-AB99-E709578C835FQ35873687-F045756A-88C5-4781-AA9E-F0C3D604B25CQ36203479-2D494934-DA96-49F8-9C52-9581607DA99BQ36243132-57436EFD-7F3F-4B4C-B0A7-8059ED7E1B51Q36540914-E0B51279-6F0F-4FFB-9350-8A30D3C1FDFAQ36708951-32DC1AD9-BBB2-4F9B-99E8-D402F16E245CQ36989832-1B6F844A-D909-4464-AEE4-2CB63DBAA574Q37008114-3957C642-79FB-4ECB-B575-2EE9C1E53E36Q37329175-B8077E18-E06D-4AD5-A47F-2A2F0264068DQ38407603-CE2F9EF5-2F99-4EAE-BFFA-56B06C974B75Q38683483-9F8B7897-0441-4D96-8865-EC67C2948DEEQ40342867-E2367EEE-5BD6-4A4C-A2B2-54B9CFEFBB71Q41054488-83F7A87B-6402-4947-A911-A7109ADDD088Q42664210-EF058C30-5CD6-41DB-9477-E35F3A1B813AQ43580817-71B0DBD4-9EA5-45A7-88D2-3BA65FE3E6A3Q44062521-34F7DA4B-B169-4816-B2E9-D8A11F06D566Q45144875-C6ED5474-1A61-463E-A4B7-2047A3A92180Q45766133-6EDEB60B-062F-46D0-A985-EA33CDE420BCQ46886437-DC4C1480-AD01-43C9-A7B2-2175A3F17E01Q46886466-5DF186C3-4413-4DBC-8762-820149E24E28Q53686438-6003F034-CAE1-4872-BFEC-71C7DD9290E0
P2860
Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Genetic polymorphisms of cytoc ...... cancer in a French population.
@ast
Genetic polymorphisms of cytoc ...... cancer in a French population.
@en
type
label
Genetic polymorphisms of cytoc ...... cancer in a French population.
@ast
Genetic polymorphisms of cytoc ...... cancer in a French population.
@en
prefLabel
Genetic polymorphisms of cytoc ...... cancer in a French population.
@ast
Genetic polymorphisms of cytoc ...... cancer in a French population.
@en
P2093
P1476
Genetic polymorphisms of cytoc ...... cancer in a French population
@en
P2093
M Miyamoto
M Oscarson
N Ariyoshi
S Rebuissou
T Kamataki
P356
10.1097/00008571-200102000-00005
P577
2001-02-01T00:00:00Z